A new study has found that in statin users, prostate cancer screening results differ, leading to over-diagnosis, meaning men are detected with low-risk prostate cancer that does not pose a risk. The study also found that statin use did not increase the risk of prostate cancer in statin users.
Scientists at the University of Montreal have explained a new mechanism that could help prevent cancers. They said any defect in the proteasome, a machine that manages and eliminates waste from cells, could give rise to cancers and neurodegenerative disorders.
A new study has found that probiotics could help break down cancer cell defenses, giving therapies that could be useful and effective. Researchers at the University of Cincinnati engineered a probiotic design that was found effective at breaking down cancer cell defenses.
Aptevo Therapeutics, a Seattle-based biotechnology company, announced positive clinical data from its Phase Ib trial, reporting a complete remission of acute myeloid leukemia in a patient who received its experimental therapy – APVO436.
Researchers at the University of Utah have explained how moles and melanomas are formed and how moles can change into melanomas. Melanoma is a type of skin cancer, while moles are typically harmless, but they may turn into melanomas.
Merck’s blockbuster cancer drug Keytruda (pembrolizumab) has been approved for adjuvant treatment of renal cell carcinoma (kidney cancer) in patients who are at risk of recurrence after nephrectomy. Keytruda has already been approved for other cancers.
A study has found that arginine, also called L-arginine, enhanced the efficacy of radiation therapy in cancer patients with brain metastasis. The study findings suggest that arginine might be useful more broadly as an anticancer therapy.